Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL.

MacFarlane M, Ahmad M, Srinivasula SM, Fernandes-Alnemri T, Cohen GM, Alnemri ES.

J Biol Chem. 1997 Oct 10;272(41):25417-20.

2.

Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway.

Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J, Hood L.

Immunity. 1997 Dec;7(6):821-30.

3.

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwin RG, Rauch CT.

EMBO J. 1997 Sep 1;16(17):5386-97.

4.

An antagonist decoy receptor and a death domain-containing receptor for TRAIL.

Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM.

Science. 1997 Aug 8;277(5327):815-8.

5.
6.
8.
9.

TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cells.

Uno K, Inukai T, Kayagaki N, Goi K, Sato H, Nemoto A, Takahashi K, Kagami K, Yamaguchi N, Yagita H, Okumura K, Koyama-Okazaki T, Suzuki T, Sugita K, Nakazawa S.

Blood. 2003 May 1;101(9):3658-67.

10.

CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis.

Inohara N, Koseki T, Hu Y, Chen S, Núñez G.

Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10717-22.

11.

Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2.

Mérino D, Lalaoui N, Morizot A, Schneider P, Solary E, Micheau O.

Mol Cell Biol. 2006 Oct;26(19):7046-55.

12.

Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.

Suliman A, Lam A, Datta R, Srivastava RK.

Oncogene. 2001 Apr 19;20(17):2122-33.

13.

Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5.

Jin TG, Kurakin A, Benhaga N, Abe K, Mohseni M, Sandra F, Song K, Kay BK, Khosravi-Far R.

J Biol Chem. 2004 Dec 31;279(53):55594-601.

14.
15.

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors.

Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P, Ashkenazi A.

Science. 1997 Aug 8;277(5327):818-21.

16.

Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.

Hesry V, Piquet-Pellorce C, Travert M, Donaghy L, Jégou B, Patard JJ, Guillaudeux T.

Prostate. 2006 Jun 15;66(9):987-95.

PMID:
16541419
17.

Chemical sensitization and regulation of TRAIL-induced apoptosis in a panel of B-lymphocytic leukaemia cell lines.

Kang J, Kisenge RR, Toyoda H, Tanaka S, Bu J, Azuma E, Komada Y.

Br J Haematol. 2003 Dec;123(5):921-32.

PMID:
14632785
18.
19.

CASH, a novel caspase homologue with death effector domains.

Goltsev YV, Kovalenko AV, Arnold E, Varfolomeev EE, Brodianskii VM, Wallach D.

J Biol Chem. 1997 Aug 8;272(32):19641-4.

20.
Items per page

Supplemental Content

Support Center